C07D 417/04
Directly linked by a ring-member-to-ring-member bond
Official title: directly linked by a ring-member-to-ring-member bond
C07D417/04 (Directly linked by a ring-member-to-ring-member bond) appears on 4,378 US grants and 4,949 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,378
- Published applications
- 4,949
- Assignees
- 1,714
- Inventors
- 14,432
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 27 | 0 |
| 1977 | 29 | 0 |
| 1978 | 12 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 10 | 0 |
| 1982 | 2 | 0 |
| 1983 | 7 | 0 |
| 1984 | 23 | 0 |
| 1985 | 24 | 0 |
| 1986 | 24 | 0 |
| 1987 | 38 | 0 |
| 1988 | 30 | 0 |
| 1989 | 44 | 0 |
| 1990 | 33 | 0 |
| 1991 | 42 | 0 |
| 1992 | 47 | 0 |
| 1993 | 57 | 0 |
| 1994 | 57 | 0 |
| 1995 | 53 | 0 |
| 1996 | 74 | 0 |
| 1997 | 88 | 0 |
| 1998 | 76 | 0 |
| 1999 | 58 | 0 |
| 2000 | 59 | 0 |
| 2001 | 53 | 14 |
| 2002 | 81 | 66 |
| 2003 | 78 | 125 |
| 2004 | 71 | 201 |
| 2005 | 64 | 205 |
| 2006 | 95 | 193 |
| 2007 | 117 | 194 |
| 2008 | 113 | 210 |
| 2009 | 132 | 228 |
| 2010 | 159 | 272 |
| 2011 | 146 | 242 |
| 2012 | 197 | 212 |
| 2013 | 196 | 222 |
| 2014 | 211 | 257 |
| 2015 | 231 | 236 |
| 2016 | 177 | 216 |
| 2017 | 171 | 216 |
| 2018 | 184 | 202 |
| 2019 | 178 | 227 |
| 2020 | 147 | 209 |
| 2021 | 139 | 174 |
| 2022 | 120 | 183 |
| 2023 | 104 | 198 |
| 2024 | 90 | 173 |
| 2025 | 125 | 168 |
| 2026 | 74 | 106 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Pyrazolyl compounds as KV7 channel activators29 Sep 2026US 12,747,237 B2
- Preparation method for pyrimidine-2-amine8 Sep 2026US 12,729,185 B2Institute for Basic Science
- Aryltetrahydropyridazine derivative or salt thereof, insecticidal agent containing the compound, and method of use thereof1 Sep 2026US 12,723,036 B2Nihon Nohyaku Co., Ltd.
- D-luciferin, D-luciferin derivative, precursor of these compounds and method for producing these compounds25 Aug 2026US 12,715,842 B2Kanto Denka Kogyo Co., Ltd.
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Therapeutic compounds24 Sep 2026US 2026/0285836 A1Rutgers, The State University of New Jersey
- Bleach Catalyst and Composition Comprising Said Catalyst24 Sep 2026US 2026/0286254 A1Reckitt Benckiser Vanish B.V.
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors249US 7,598,257 B2Incyte Corporation · 2009
- Substituted 2-anilinopyrimidines useful as protein kinase inhibitors201US 5,958,935 ACelltech Therapeutics Limited · 1999
- Substituted 2-anilinopyrimidines useful as protein kinase inhibitors189US 6,235,746 B1Celltech Therapeutics Limited · 2001
- 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation161US 5,817,677 ADr. Karl Thomae GmbH · 1998